| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YJMCC.2015.05.017 |
| P698 | PubMed publication ID | 26027783 |
| P50 | author | Filippo Perbellini | Q85263637 |
| Carolyn A. Carr | Q77207197 | ||
| P2093 | author name string | Carolyn A Carr | |
| Filippo Perbellini | |||
| P2860 | cites work | Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction | Q24534652 |
| Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites | Q24794781 | ||
| Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction | Q27318070 | ||
| Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients | Q27347592 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Multilineage cells from human adipose tissue: implications for cell-based therapies | Q29547688 | ||
| Immunogenicity of induced pluripotent stem cells | Q29616185 | ||
| RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 | ||
| Human umbilical cord blood cells improve cardiac function after myocardial infarction | Q81223159 | ||
| Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes | Q82662208 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | Q33340205 | ||
| Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes | Q33804692 | ||
| Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function | Q33941111 | ||
| Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. | Q34133412 | ||
| Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. | Q34241616 | ||
| Paracrine mechanisms of stem cell reparative and regenerative actions in the heart | Q34494230 | ||
| Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine | Q34523235 | ||
| Peripheral blood-derived mesenchymal stem cells: candidate cells responsible for healing critical-sized calvarial bone defects | Q35200160 | ||
| Meta-analysis of cell therapy trials for patients with heart failure | Q35551127 | ||
| Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells | Q35666637 | ||
| Myocardial repair and regeneration: bone marrow or cardiac stem cells? | Q36014092 | ||
| Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
| Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells | Q36590207 | ||
| Extracellular antigen processing and presentation by immature dendritic cells | Q36780502 | ||
| Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application | Q36998274 | ||
| Structure and function of major histocompatibility complex class I antigens | Q37012868 | ||
| Stem-cell therapy for cardiac disease | Q37089732 | ||
| Skeletal myoblast transplantation for repair of myocardial necrosis | Q37361791 | ||
| Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) | Q37625636 | ||
| Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing | Q37988753 | ||
| Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes | Q38179199 | ||
| The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult. | Q38212535 | ||
| Murine cardiosphere-derived cells are impaired by age but not by cardiac dystrophic dysfunction. | Q38920803 | ||
| Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction | Q41888608 | ||
| Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair | Q42794686 | ||
| Altered expression of C/EBP family members results in decreased adipogenesis with aging | Q43608324 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats. | Q51351109 | ||
| Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. | Q51794738 | ||
| Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy. | Q53519759 | ||
| Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. | Q53576712 | ||
| Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart. | Q54343615 | ||
| Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 | ||
| Cardiomyocyte transplantation improves heart function | Q71476830 | ||
| Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction | Q73733133 | ||
| Impact of aging on rat bone marrow-derived stem cell chondrogenesis | Q79880899 | ||
| P304 | page(s) | 127-130 | |
| P577 | publication date | 2015-05-28 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | Uterine cells-an immunoprivileged cell source for therapy-but are they for everyone? | |
| P478 | volume | 85 |
Search more.